Phase I trial of the irreversible EGFR and HER2 kinase inhibitor BIBW 2992 in patients with advanced solid tumors (Q42948964)
Jump to navigation
Jump to search
scientific article published on 2 August 2010
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Phase I trial of the irreversible EGFR and HER2 kinase inhibitor BIBW 2992 in patients with advanced solid tumors |
scientific article published on 2 August 2010 |
Statements
1 reference
Phase I trial of the irreversible EGFR and HER2 kinase inhibitor BIBW 2992 in patients with advanced solid tumors (English)
1 reference
Andrew Futreal
1 reference
Timothy A Yap
1 reference
Laura Vidal
1 reference
Jan Adam
1 reference
Peter Stephens
1 reference
James Spicer
1 reference
Heather Shaw
1 reference
Jooern Ang
1 reference
Graham Temple
1 reference
Susan Bell
1 reference
Mehdi Shahidi
1 reference
Martina Uttenreuther-Fischer
1 reference
Peter Stopfer
1 reference
Hilary Calvert
1 reference
Johann S de Bono
1 reference
Ruth Plummer
1 reference
2 August 2010
1 reference
1 reference
28
1 reference
25
1 reference
3965-3972
1 reference
Identifiers
1 reference
1 reference